ID   5HT2B_RAT               Reviewed;         479 AA.
AC   P30994; Q9QW44;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   02-OCT-2024, entry version 166.
DE   RecName: Full=5-hydroxytryptamine receptor 2B;
DE            Short=5-HT-2B;
DE            Short=5-HT2B;
DE   AltName: Full=5-HT-2F {ECO:0000303|PubMed:1331748};
DE   AltName: Full=Serotonin receptor 2B;
DE   AltName: Full=Stomach fundus serotonin receptor {ECO:0000303|PubMed:1505525};
GN   Name=Htr2b; Synonyms=Srl;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=1505525; DOI=10.1002/j.1460-2075.1992.tb05427.x;
RA   Foguet M., Hoyer D., Pardo L.A., Parekh A., Kluxen F.-W., Kalkman M.O.,
RA   Stuehmer W., Luebbert H.;
RT   "Cloning and functional characterization of the rat stomach fundus
RT   serotonin receptor.";
RL   EMBO J. 11:3481-3487(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Gastric fundus;
RX   PubMed=1331748;
RA   Kursar J.D., Nelson D.L., Wainscott D.B., Cohen M.L., Baez M.;
RT   "Molecular cloning, functional expression, and pharmacological
RT   characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from
RT   rat stomach fundus.";
RL   Mol. Pharmacol. 42:549-557(1992).
RN   [3]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22525520; DOI=10.1016/j.pain.2012.03.024;
RA   Urtikova N., Berson N., Van Steenwinckel J., Doly S., Truchetto J.,
RA   Maroteaux L., Pohl M., Conrath M.;
RT   "Antinociceptive effect of peripheral serotonin 5-HT2B receptor activation
RT   on neuropathic pain.";
RL   Pain 153:1320-1331(2012).
CC   -!- FUNCTION: G-protein coupled receptor for 5-hydroxytryptamine
CC       (serotonin) (PubMed:1331748, PubMed:1505525). Also functions as a
CC       receptor for various ergot alkaloid derivatives and psychoactive
CC       substances (PubMed:22525520). Ligand binding causes a conformation
CC       change that triggers signaling via guanine nucleotide-binding proteins
CC       (G proteins) and modulates the activity of downstream effectors
CC       (PubMed:1331748, PubMed:1505525). HTR2B is coupled to G(q)/G(11) G
CC       alpha proteins and activates phospholipase C-beta, releasing
CC       diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) second
CC       messengers that modulate the activity of phosphatidylinositol 3-kinase
CC       and promote the release of Ca(2+) ions from intracellular stores,
CC       respectively (By similarity). Beta-arrestin family members inhibit
CC       signaling via G proteins and mediate activation of alternative
CC       signaling pathways (By similarity). Plays a role in the regulation of
CC       dopamine and 5-hydroxytryptamine release, 5-hydroxytryptamine uptake
CC       and in the regulation of extracellular dopamine and 5-hydroxytryptamine
CC       levels, and thereby affects neural activity (By similarity). May play a
CC       role in the perception of pain (PubMed:22525520). Plays a role in the
CC       regulation of behavior, including impulsive behavior (By similarity).
CC       Required for normal proliferation of embryonic cardiac myocytes and
CC       normal heart development (By similarity). Protects cardiomyocytes
CC       against apoptosis (By similarity). Plays a role in the adaptation of
CC       pulmonary arteries to chronic hypoxia (By similarity). Plays a role in
CC       vasoconstriction (By similarity). Required for normal osteoblast
CC       function and proliferation, and for maintaining normal bone density (By
CC       similarity). Required for normal proliferation of the interstitial
CC       cells of Cajal in the intestine (By similarity).
CC       {ECO:0000250|UniProtKB:P41595, ECO:0000250|UniProtKB:Q02152,
CC       ECO:0000269|PubMed:1331748, ECO:0000269|PubMed:1505525,
CC       ECO:0000269|PubMed:22525520}.
CC   -!- SUBUNIT: Interacts (via C-terminus) with MPDZ.
CC       {ECO:0000250|UniProtKB:P41595}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1331748,
CC       ECO:0000269|PubMed:1505525, ECO:0000269|PubMed:22525520}; Multi-pass
CC       membrane protein {ECO:0000269|PubMed:1505525}. Synapse, synaptosome
CC       {ECO:0000250|UniProtKB:Q02152}.
CC   -!- TISSUE SPECIFICITY: Stomach fundus. {ECO:0000269|PubMed:1331748,
CC       ECO:0000269|PubMed:1505525}.
CC   -!- DOMAIN: Ligands are bound in a hydrophobic pocket formed by the
CC       transmembrane helices. {ECO:0000250|UniProtKB:P41595}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X66842; CAA47318.1; -; mRNA.
DR   PIR; S23562; S23562.
DR   RefSeq; NP_058946.1; NM_017250.1.
DR   AlphaFoldDB; P30994; -.
DR   SMR; P30994; -.
DR   BioGRID; 248214; 1.
DR   IntAct; P30994; 1.
DR   MINT; P30994; -.
DR   STRING; 10116.ENSRNOP00000023829; -.
DR   BindingDB; P30994; -.
DR   ChEMBL; CHEMBL323; -.
DR   DrugCentral; P30994; -.
DR   GuidetoPHARMACOLOGY; 7; -.
DR   GlyCosmos; P30994; 2 sites, No reported glycans.
DR   GlyGen; P30994; 2 sites.
DR   PhosphoSitePlus; P30994; -.
DR   PaxDb; 10116-ENSRNOP00000023829; -.
DR   Ensembl; ENSRNOT00065034649; ENSRNOP00065027794; ENSRNOG00065020494.
DR   GeneID; 29581; -.
DR   KEGG; rno:29581; -.
DR   UCSC; RGD:61801; rat.
DR   AGR; RGD:61801; -.
DR   CTD; 3357; -.
DR   RGD; 61801; Htr2b.
DR   eggNOG; KOG3656; Eukaryota.
DR   InParanoid; P30994; -.
DR   OrthoDB; 2880253at2759; -.
DR   PhylomeDB; P30994; -.
DR   Reactome; R-RNO-390666; Serotonin receptors.
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   PRO; PR:P30994; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0098666; C:G protein-coupled serotonin receptor complex; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; IEA:UniProtKB-SubCell.
DR   GO; GO:0004993; F:G protein-coupled serotonin receptor activity; ISS:UniProtKB.
DR   GO; GO:0001965; F:G-protein alpha-subunit binding; ISS:UniProtKB.
DR   GO; GO:0001587; F:Gq/11-coupled serotonin receptor activity; ISO:RGD.
DR   GO; GO:0005096; F:GTPase activator activity; ISS:UniProtKB.
DR   GO; GO:0030594; F:neurotransmitter receptor activity; IBA:GO_Central.
DR   GO; GO:0051378; F:serotonin binding; IDA:RGD.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0003300; P:cardiac muscle hypertrophy; ISS:UniProtKB.
DR   GO; GO:0071418; P:cellular response to amine stimulus; IDA:RGD.
DR   GO; GO:1904015; P:cellular response to serotonin; IDA:RGD.
DR   GO; GO:0071502; P:cellular response to temperature stimulus; ISS:UniProtKB.
DR   GO; GO:0019934; P:cGMP-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0048598; P:embryonic morphogenesis; ISS:UniProtKB.
DR   GO; GO:0070371; P:ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0002031; P:G protein-coupled receptor internalization; ISO:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007187; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; IBA:GO_Central.
DR   GO; GO:0098664; P:G protein-coupled serotonin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0003007; P:heart morphogenesis; ISS:UniProtKB.
DR   GO; GO:0035733; P:hepatic stellate cell activation; IEP:RGD.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; IEP:RGD.
DR   GO; GO:0014827; P:intestine smooth muscle contraction; ISS:UniProtKB.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0034220; P:monoatomic ion transmembrane transport; IDA:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0014033; P:neural crest cell differentiation; ISS:UniProtKB.
DR   GO; GO:0001755; P:neural crest cell migration; ISS:UniProtKB.
DR   GO; GO:0043491; P:phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISS:UniProtKB.
DR   GO; GO:0007208; P:phospholipase C-activating serotonin receptor signaling pathway; ISO:RGD.
DR   GO; GO:0016310; P:phosphorylation; ISS:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:0051781; P:positive regulation of cell division; ISS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0001819; P:positive regulation of cytokine production; ISS:UniProtKB.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; ISS:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0051000; P:positive regulation of nitric-oxide synthase activity; ISS:UniProtKB.
DR   GO; GO:0010513; P:positive regulation of phosphatidylinositol biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0070528; P:protein kinase C signaling; ISS:UniProtKB.
DR   GO; GO:0007205; P:protein kinase C-activating G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0050795; P:regulation of behavior; ISS:UniProtKB.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; ISS:UniProtKB.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0007210; P:serotonin receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0042310; P:vasoconstriction; ISS:UniProtKB.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR000482; 5HT2B_rcpt.
DR   InterPro; IPR002231; 5HT_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR24247; 5-HYDROXYTRYPTAMINE RECEPTOR; 1.
DR   PANTHER; PTHR24247:SF31; 5-HYDROXYTRYPTAMINE RECEPTOR 2B; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00651; 5HT2BRECEPTR.
DR   PRINTS; PR01101; 5HTRECEPTOR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   Behavior; Cell membrane; Disulfide bond; G-protein coupled receptor;
KW   Glycoprotein; Lipoprotein; Membrane; Palmitate; Receptor;
KW   Reference proteome; Synapse; Synaptosome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..479
FT                   /note="5-hydroxytryptamine receptor 2B"
FT                   /id="PRO_0000068956"
FT   TOPO_DOM        1..55
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   TRANSMEM        56..78
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   TOPO_DOM        79..89
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   TRANSMEM        90..112
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   TOPO_DOM        113..128
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   TRANSMEM        129..150
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   TOPO_DOM        151..170
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   TRANSMEM        171..191
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   TOPO_DOM        192..215
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   TRANSMEM        216..238
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   TOPO_DOM        239..323
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   TRANSMEM        324..344
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   TOPO_DOM        345..359
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   TRANSMEM        360..381
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   TOPO_DOM        382..479
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   MOTIF           151..153
FT                   /note="DRY motif; important for ligand-induced conformation
FT                   changes"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   MOTIF           211..214
FT                   /note="[DE]RFG motif; may stabilize a conformation that
FT                   preferentially activates signaling via beta-arrestin family
FT                   members"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   MOTIF           375..379
FT                   /note="NPxxY motif; important for ligand-induced
FT                   conformation changes and signaling"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   MOTIF           477..479
FT                   /note="PDZ-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   BINDING         134
FT                   /ligand="ergotamine"
FT                   /ligand_id="ChEBI:CHEBI:190463"
FT                   /ligand_note="agonist"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   BINDING         139
FT                   /ligand="ergotamine"
FT                   /ligand_id="ChEBI:CHEBI:190463"
FT                   /ligand_note="agonist"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   BINDING         208
FT                   /ligand="ergotamine"
FT                   /ligand_id="ChEBI:CHEBI:190463"
FT                   /ligand_note="agonist"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   SITE            208
FT                   /note="Hydrophobic barrier that decreases the speed of
FT                   ligand binding and dissociation"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   LIPID           396
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        203
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        353
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        127..206
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   DISULFID        349..352
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   CONFLICT        281
FT                   /note="V -> A (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        296
FT                   /note="T -> I (in Ref. 2; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   479 AA;  53652 MW;  17FFC73213B42038 CRC64;
     MASSYKMSEQ STISEHILQK TCDHLILTDR SGLKAESAAE EMKQTAENQG NTVHWAALLI
     FAVIIPTIGG NILVILAVSL EKRLQYATNY FLMSLAVADL LVGLFVMPIA LLTIMFEATW
     PLPLALCPAW LFLDVLFSTA SIMHLCAISL DRYIAIKKPI QANQCNSRTT AFVKITVVWL
     ISIGIAIPVP IKGIEADVVN AHNITCELTK DRFGSFMLFG SLAAFFAPLT IMIVTYFLTI
     HALRKKAYLV RNRPPQRLTR WTVSTVLQRE DSSFSSPEKM VMLDGSHKDK ILPNSTDETL
     MRRMSSAGKK PAQTISNEQR ASKVLGIVFL FFLLMWCPFF ITNVTLALCD SCNQTTLKTL
     LQIFVWVGYV SSGVNPLIYT LFNKTFREAF GRYITCNYQA TKSVKVLRKC SSTLYFGNSM
     VENSKFFTKH GIRNGINPAM YQSPVRLRSS TIQSSSIILL NTFLTENDGD KVEDQVSYI
//
